Dynavax Technologies (DVAX) Revenue (2016 - 2025)
Historic Revenue for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $94.9 million.
- Dynavax Technologies' Revenue rose 1766.84% to $94.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.5 million, marking a year-over-year increase of 2672.55%. This contributed to the annual value of $277.2 million for FY2024, which is 1935.65% up from last year.
- As of Q3 2025, Dynavax Technologies' Revenue stood at $94.9 million, which was up 1766.84% from $95.4 million recorded in Q2 2025.
- Dynavax Technologies' 5-year Revenue high stood at $256.5 million for Q2 2022, and its period low was $46.9 million during Q1 2023.
- For the 5-year period, Dynavax Technologies' Revenue averaged around $101.6 million, with its median value being $80.6 million (2024).
- As far as peak fluctuations go, Dynavax Technologies' Revenue skyrocketed by 187777.36% in 2021, and later crashed by 7650.78% in 2023.
- Quarter analysis of 5 years shows Dynavax Technologies' Revenue stood at $195.1 million in 2021, then fell by 5.42% to $184.5 million in 2022, then plummeted by 69.87% to $55.6 million in 2023, then increased by 29.56% to $72.0 million in 2024, then soared by 31.71% to $94.9 million in 2025.
- Its Revenue stands at $94.9 million for Q3 2025, versus $95.4 million for Q2 2025 and $68.2 million for Q1 2025.